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Introduction
As of July 2022, the cumulative, confirmed COVID-19 mortality rates in the
United States (U.S.) and India are roughly 3,000 and 370 deaths per 100,000 population,
respectively (1). Rates are far lower in India vs. the United States, despite the U.S.,
dedicating 14% more of their gross domestic product (GDP) on healthcare spending than
India (Table 1). However, COVID-19 mortality rates in India have been highly contested.
COVID-19 mortality in India has been referred to as the “Indian death paradox” (2)
because the death rate is disproportionately low relative to the number of COVID19 cases the country has experienced. We examine the two most evidence-based and
plausible explanations of India’s low death rates during the COVID-19 pandemic, which
are (1) demographic dynamics and (2) factors contributing to increasing divergence in
COVID-19 mortality in the U.S. vs. India, including the systematic undercounting of
deaths in India.
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data released by the Ministry of Health and Family Welfare
(MoHFW) show the age-wise share of COVID-19 deaths at older
ages (i.e., 60 years and above) is ∼50%, with 46% of deaths
occurring in the prime adult ages of 30–60 years, with a median
age at death of 60 years. This is almost 20 years lower than
what applies in high-income countries. Although India’s death
toll is large due to the sheer size of its population, its COVID-19
mortality rate per capita is relatively low due to a relatively young
age structure. Currently, only about 7% of India’s population is
65 years and older. By 2050, however, that number is expected
to approximately double to about 15%, and double again to
∼30% by the year 2100 (5). Since the risk of dying of COVID19 increases with age globally and is greatest in older adults,
one plausible theory is that India, with a younger demographic
makeup, has a lower risk of death on a population level.
Additionally, other demographic characteristics, such as
gender, contributed to cross-national COVID-19 death rate
disparities. In the United States, as of September 2022, 55.1%
of COVID-19 deaths were in men, 44.9% of COVID-19 deaths
were in women while COVID-19 death counts for other sex
and gender minorities are not available (6). Similarly, in India,
as of 18 May 2021, 64% of deaths were in men while 36% of
deaths were in women, with no data on other sex and gender
minorities (7). As of 9 April 2022, the male to female ratio for
deaths in the U.S. among confirmed cases was 1.39, with the
oldest aged men (80 plus years) at the greatest disadvantage
for COVID-19 deaths, followed by women of 80 plus years.
However, early in the pandemic in India, men were at a greater
disadvantage than women with a case fatality rate (CFR) of 3.3
and 2.9%, respectively, where the CFR was estimated as the ratio
of confirmed deaths to the total number of confirmed cases (8).

TABLE 1 Economic and demographic inequalities in the United States
vs. India.

Population
characteristics

United States

India

Economic inequalities
Income classification

High-income

Lower middle income

GNI per capita, USD

70,430

2,170

17

3

Developed

Developing

334.81 M

1.41 B

(2021)
GDP spent on
healthcare (%)
Overall development
(United Nations)
Demographic
inequalities
2022 Population
Men (n, %)

162.76 M, 48.6

730 M, 52

Women (n, %)

171 M, 51.1

675 M, 48.1

Age > 65 years (n, %)

56 M, 16.9

98 M, 7.0

79.1

70.4

Life expectancy in
years
Overall
Female: Male

81.7: 76.6

71.8: 69.2

Age dependency ratio

55

48

1.782

2.159

(2021)*
Fertility rate (births
per women) (2022)
Notes: M, Millions; B, Billions, GNI, Gross National Income; GDP, Gross Domestic
Product.
* Age dependency ratio (% of working-age population).
https://worldpopulationreview.com/country-rankings/highSource:
income-countries.
https://www.worldometers.info/demographics/life-expectancy/.
https://data.worldbank.org/indicator/SP.POP.DPND?locations=IN.
https://www.statista.com/statistics/737923/us-population-by-gender/.

Causes and factors contributing to
differentials in COVID-19 incidence
and fatality

https://www.theglobalstatistics.com/india-population-statistics/#:
$\sim$:text=In%202022%2C%20males%20make%20up,total
%20population%20at%20675%20million.
https://www.americashealthrankings.org/explore/senior/measure/pct_
65plus/state/ALL?edition-year=2022.

Globally, the age pattern of the COVID-19 pandemic cases
points to a near normal distribution with three-fifths of the
cases concentrated in adults aged 30–65 years. In contrast, the
fatality rate is very high for older adults aged 60 years and
above compared with younger adults aged <60 years. Second,
the age gradients of COVID-19 mortality demonstrate sharp
differences between high- and middle-income countries; with
stepper age gradients for high-income countries compared with
moderating age gradient for lower middle-income countries,
such as India. Third, biological sex differences are shown to
contribute to excess male COVID-19 deaths at older ages.
However, data suggest gender-associated risk of exposure may
affect rates of infection and fatality differently for men and
women (9). Fourth, during the pandemic, the age-associated
chronic diseases has taken millions of lives annually and a
larger share of younger lives ages 30–70 years in low- and

Demographic dynamics
Cumulative global COVID-19 data show older adults ages
65 years and above, and older men, to be extremely vulnerable to
COVID-19 fatality. Early in the pandemic, 8 out of 10 COVID19 reported deaths in the United States were in older adults
65 years and above (3). Overall, the age gradients of COVID19 mortality are steeper in the low mortality settings of highincome countries. The case fatality rate (CFR) of COVID-19 for
older adults ages 65 years and above is 15 times higher than
for younger adults (3, 4). Low-and middle-income countries
display relatively moderate age gradients of COVID-19, where
population age structures are comparatively young. In India,
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middle-income countries (LMIC’s) comprise the global burden
(10). The premature onset of chronic health conditions among
older adults aged 45 years and above is more common in
LIMCs with workforces in these ages exposed to heightened
risks of contracting COVID-19; this shifts the share of COVID19 mortality from older adult ages to younger adult ages
of 30–60 years. About 90% of COVID-19 deaths of older
adults are assigned causes associated with pre-existing chronic
health conditions, such as cardiovascular diseases, diabetes,
kidney disease, respiratory system disease, and cancer (11, 12).
Finally, the huge humanitarian and economic crisis of the
COVID-19 pandemic led to a disproportionate burden on
the health and mortality impact on the poor and vulnerable,
bringing existing socioeconomic disparities in health into
sharper focus.

in rural, less affluent areas in India. With the worldwide
healthcare infrastructure and human resources of health set
exclusively for COVID-19 priority during the lockdown, people
in urgent/emergency need of critical healthcare for pre-existing
chronic health conditions, acute conditions, and maternity and
childcare, faced either no access to care or extremely limited
access. This led to a sizeable number of deaths from other causes;
most countries reported disruption to healthcare services for
non-communicable diseases (NCDs) (12).

Undercounting of deaths in India
Measuring mortality in India is difficult. About half of India’s
deaths occur at home (21). Of 10 million deaths every year,
over 3 million are not registered and over 8 million have not
undergone medical certification (22). A quarter of women’s
deaths are not counted (23) and registration is especially low in
the poorest states, such as Uttar Pradesh and Bihar (24).
In contrast, the completeness and accuracy of the US
mortality reporting are generally more reliable, even during the
COVID-19 pandemic (25). However, even in the United States,
COVID-19 deaths have been somewhat undercounted in certain
areas of the country, namely, rural areas and in the southern
states (26). The Centers for Disease Control and Prevention
(CDC) estimates that overall U.S. excess deaths between March
2020 and March 2022 totaled 1,105,736, which was only 15%
more than the 958,864 official death toll reported from COVID19 over that period (3).
Methodologically, excess mortality is the best way to
estimate the total net mortality burden of the COVID-19
pandemic. Excess mortality is the difference between the
observed deaths and the expected number of deaths during the
same time period, based on data from years before the pandemic.
Thus, the “excess deaths” estimate the extra number of deaths
from all causes during the pandemic relative to what would have
been expected, had the pandemic not occurred.
In May 2022, the World Health Organization (WHO)
released a report estimating the global mortality burden of
the COVID-19 pandemic to be 14.9 million excess deaths,
in contrast to the 5.4 million COVID-19 deaths that had
been officially reported. This report claims, of these deaths, a
cumulative 4.7 million deaths due to COVID-19 occurred in
India alone (27), whereas India’s official estimates place the total
at ∼525,000 as of July 2022 (22). Furthermore, two other large
studies of deaths in India during the COVID-19 pandemic also
estimated India’s excess mortality to be 6–8.3 times higher than
expected (22, 24), with much variability in the ratios of observed
to expected between Indian states (from 0.96 in Goa to 26.7
in Bihar) (24). For a more realistic count of excess mortality,
researchers must wait until all-cause mortality data for the
COVID-19 period (March 2020 to December 2021) is released
from the Sample Registration System (SRS), possibly in 2024.

Socioeconomic disparities in
COVID-19 incidence and fatality
Across the world, COVID-19 incidence and fatalities are
distributed unequally among those with different levels of
material and social deprivation (13). People living in congested
poor urban settlements, migrant wage earners in low- and
middle-income countries, racial minorities in high-income
countries, and the frontline healthcare workforce at the bottom
of the hierarchical spectrum have borne a disproportionately
heavy burden of infection and death. The COVID-19 pandemic
has brought such existing socioeconomic health disparities
into sharper focus both in the United States and in India
(14). India and the United States have different and unique
underlying socioeconomic and structural determinants across
many domains and levels of influence (9, 15–19). These so
called upstream drivers of disparities rooted in historical, social,
political, and cultural determinants have intersected during
the COVID-19 pandemic and have amplified and exposed
the underlying and existing disparities within specific country
contexts, thereby creating inequities in COVID-19 mortality.
The demographic and socioeconomic disparities in the health
gradient provide an important framework to deepen the
understanding of, and to mitigate, the health equity effects
of the disease (13). According to the OXFAM International
report on extreme inequality numbers in India, the lack
of universal health coverage in India is one of the drivers
of socio-economic inequalities in the health sector, which
disproportionately affects health outcomes of marginalized
communities (20).
Additionally, the waves of COVID-19 lockdown and related
measures across States and Union Territories in India have led
to state variations in COVID-19 incidence and deaths (Table 1).
There has been a huge humanitarian and economic crisis
with heavier burdens of COVID-19-related health consequences
for the poor and vulnerable. Excess mortality was greater
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FIGURE 1

Population projections of age structure and virus age-speciﬁc deaths in India. United Nations. Department of Economic and Social Affairs,
Population Division, World population prospects 2022, Source: https://population.un.org/wpp/Download/Standard/Population/.

Conclusion

health information in India in general, is the lack of consistency
and completeness in public health data and vital statistics. The
contrast between the United States and India’s excess mortality
highlights these disparities in the public health infrastructure,
limited medical care for critically ill patients in a large-scale
health crisis, and a lack of vital recordkeeping capacities. Before
the next pandemic, developing nations, such as India, need to
prioritize investments in more resilient health systems that can
sustain essential health services during crises, including stronger
health information systems.

A future pandemic is inevitable. A pandemic caused
by a virus with mortality rates similar to severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), which kills
proportionately more older people in a pattern that follows
“Gompertz’ Law” (28), would become increasingly deadly as
India’s falling fertility rates, negative net migration of mostly
young people, and rapidly growing life expectancy (29) and
rising longevity produce proportionally older populations over
time (Figure 1). The same “COVID-19-like” virus scaled to kill
1 million people in India in 2022 would kill just over 2 million
in 2050, and 3 million in 2100. Thus, changes in age structure
alone would result in more deadly pandemics in the near and
distant future. A potential limitation of this assessment, and of
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